Abstract

Patients with asthma typically have chronic airway inflammation, variable airflow limitation, and intermittent respiratory symptoms; patients with chronic obstructive pulmonary disease (COPD) often have fixed airflow limitation and persistent respiratory symptoms. Some patients exhibit features suggesting that they have both conditions, which is termed asthma-COPD overlap. These patients have been reported to have worse health outcomes than do those with asthma or COPD alone (1). To describe mortality among persons aged ≥25 years with asthma-COPD overlap, CDC analyzed 1999-2016 National Vital Statistics multiple-cause-of-death mortality data* extracted from the National Occupational Mortality System (NOMS), which included industry and occupation† information collected from 26 states§ for the years 1999, 2003, 2004, and 2007-2014. Age-adjusted death rates per one million persons¶ and proportionate mortality ratios (PMRs)** were calculated. During 1999-2016, 6,738 male decedents (age-adjusted rate per million=4.30) and 12,028 female decedents (5.59) had both asthma and COPD assigned on their death certificate as the underlying or contributing cause of death. The annual age-adjusted death rate per million among decedents with asthma-COPD overlap declined from 6.70 in 1999 to 3.01 in 2016 (p<0.05) for men and from 7.71 in 1999 to 4.01 in 2016 (p<0.05) for women. Among adults aged 25-64 years, asthma-COPD overlap PMRs, by industry, were significantly elevated among nonpaid workers, nonworkers, and persons working at home for both men (1.72) and women (1.40) and among male food, beverage, and tobacco products workers (2.64). By occupation, asthma-COPD overlap PMRs were significantly elevated among both men (1.98) and women (1.79) who were unemployed, had never worked, or were disabled workers and among women bartenders (3.28) and homemakers (1.34). The association between asthma-COPD overlap mortality and nonworking status among adults aged 25-64 years suggests that asthma-COPD overlap might be associated with substantial morbidity. Increased risk for asthma-COPD overlap mortality among adults in certain industries and occupations suggests targets for public health interventions (e.g., elimination of or removal from exposures, engineering controls, and workplace smoke-free policies) to prevent asthma and COPD in and out of the workplace.

Highlights

  • The association between asthma-chronic obstructive pulmonary disease (COPD) overlap mortality and nonworking status among adults of working age (25–64 years) suggests that asthma-COPD overlap might be associated with substantial morbidity resulting in loss of employment

  • Continued surveillance for asthma-chronic obstructive pulmonary disease (COPD) overlap morbidity and mortality is essential to inform policy and intervention activities

Read more

Summary

Morbidity and Mortality Weekly Report

Mortality Among Persons with Both Asthma and Chronic Obstructive Pulmonary Disease Aged ≥25 Years, by Industry and Occupation — United States, 1999–2016. To describe mortality among persons aged ≥25 years with asthma-COPD overlap, CDC analyzed 1999–2016 National Vital Statistics multiple-cause-of-death mortality data* extracted from the National Occupational Mortality System (NOMS), which included industry and occupation† information collected from 26 states§ for the years 1999, 2003, 2004, and 2007–2014. Occupation, coded by the National Institute for Occupational Safety and Health using the U.S Census 2000 Industry and Occupation Classification System, was available from 26 states for the years 1999, 2003, 2004, and 2007–2014.¶¶ PMRs, relative to the expected number of decedents with asthma-COPD overlap, and 95% confidence intervals (CIs) were generated by industry and occupation for men and women and adjusted for 5-year age groups and race. Number of asthma and chronic obstructive pulmonary disease (COPD) overlap deaths* and age-adjusted asthma-COPD overlap death rates† among decedents aged ≥25 years, by sex — United States, 1999–2016

No of deaths
Discussion
What is added by this report?
What are the implications for public health practice?
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call